Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 4/20 | 0.37 |
| ▸ | ANPEP | P15144 | 3/20 | 0.37 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.37 |
| ▸ | CTSA | P10619 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12038322 | 0.83 | CTSA (0.36) | LAP3ANPEPERAP1CTSAACHE | |
| SCHEMBL1698632 | 0.79 | — | — | |
| SCHEMBL4738766 | 0.77 | LAP3 (0.37) | LAP3ANPEPERAP1 | |
| SCHEMBL1698634 | 0.76 | METAP1 (0.36) | — | |
| SCHEMBL4319783 | 0.73 | LAP3 (0.46) | LAP3ANPEPERAP1CTSAACHE | |
| SCHEMBL18826043 | 0.73 | LAP3 (0.46) | LAP3ANPEPERAP1 | |
| SCHEMBL25787055 | 0.73 | LAP3 (0.46) | LAP3ANPEPERAP1 | |
| SCHEMBL8020240 | 0.73 | ANPEP (0.31) | LAP3ANPEPERAP1 | |
| SCHEMBL18535335 | 0.73 | ANPEP (0.31) | LAP3ANPEPERAP1 | |
| SCHEMBL159529 | 0.71 | RNPEP (0.31) | LAP3ANPEPERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791056-B2 | Alkylphosphorofluoridothioates having low wear volume and methods for synthesizing and using same | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-07-29 | — | — | US | disclosed |
| US-20110319303-A1 | ALKYLPHOSPHOROFLUORIDOTHIOATES HAVING LOW WEAR VOLUME AND METHODS FOR SYNTHESIZING AND USING SAME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-12-29 | — | — | US | disclosed |
| WO-2011163592-A2 | ALKYLPHOSHOROFLUORIDOTHIOATES HAVING LOW WEAR VOLUME AND METHODS FOR SYNTHESIZING AND USING SAME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319303-A1 | ALKYLPHOSPHOROFLUORIDOTHIOATES HAVING LOW WEAR VOLUME AND METHODS FOR SYNTHESIZING AND USING SAME | ACR, MTAP, PLTP | LAP3 2795/4885ANPEP 828/4885ERAP1 1740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.